According to GlobalData’s medical device pipeline database, 14 Implantable Infusion Pumps devices are in various stages of development globally. GlobalData’s report Implantable Infusion Pumps provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, five are in active development, while the remaining nine are in an inactive stage of development. There are three products in the early stages of development, and the remaining two are in the late stages of development.
Drug delivery devices are used for administration of drug compounds in effective ways. Implantable Infusion Pump is a drug delivery system which provides continuous infusion of an agent at a constant and precise rate. This consists of a clinician programmer which is an external component. The programmer is equipped with a touch screen display for data entry, telemetry head for device programming, and an infrared port through which communications can be established with compatible printers. Only Implantable infusion pumps are tracked here, external clinician programmer is not considered.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Implantable Infusion Pumps pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Implantable Infusion Pumps devices. Overall, most of these Implantable Infusion Pumps pipeline devices are being developed by private entities.
Key players involved in the active development of Implantable Infusion Pumps include Massachusetts Institute of Technology, Sree Chitra Tirunal Institute for Medical Sciences & Technology, University of Minnesota, University of Southern California, Agitated Solutions, Alnylam Pharmaceuticals, Cognos Therapeutics, Debiotech, Eksigent Technologies and Eli Lilly and Co.
For a complete picture of the developmental pipeline for Implantable Infusion Pumps devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.